<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Costa-Machado LF</submitter><funding>Austrian Science Fund FWF</funding><funding>ZonMw</funding><funding>Ministerio de Educación, Cultura y Deporte</funding><funding>Fundación Científica Asociación Española Contra el Cáncer</funding><funding>Generalitat Valenciana</funding><funding>NIH HHS</funding><pagination>2779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10185515</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mit</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models.</pubmed_title><pmcid>PMC10185515</pmcid><funding_grant_id>W 1226</funding_grant_id><funding_grant_id>MGS/2021/15</funding_grant_id><funding_grant_id>CIDENGENT/2019/044</funding_grant_id><funding_grant_id>P40 OD010440</funding_grant_id><funding_grant_id>91715305</funding_grant_id><funding_grant_id>LABAE18008FERN</funding_grant_id><funding_grant_id>P 27893</funding_grant_id><funding_grant_id>P 29203</funding_grant_id><funding_grant_id>P 31727</funding_grant_id><funding_grant_id>OP ERDF</funding_grant_id><funding_grant_id>TAI 602</funding_grant_id><funding_grant_id>P 33957</funding_grant_id><funding_grant_id>P 29262</funding_grant_id><pubmed_authors>Plaza A</pubmed_authors><pubmed_authors>Eisenberg T</pubmed_authors><pubmed_authors>Gomez-Cabrera MC</pubmed_authors><pubmed_authors>Duerr JS</pubmed_authors><pubmed_authors>Vina J</pubmed_authors><pubmed_authors>Costa-Machado LF</pubmed_authors><pubmed_authors>Hofer SJ</pubmed_authors><pubmed_authors>Loza MI</pubmed_authors><pubmed_authors>Villanueva-Bermejo D</pubmed_authors><pubmed_authors>Magnes C</pubmed_authors><pubmed_authors>Perez M</pubmed_authors><pubmed_authors>Del Pino I</pubmed_authors><pubmed_authors>Pozo OJ</pubmed_authors><pubmed_authors>Garcia-Dominguez E</pubmed_authors><pubmed_authors>Fornari T</pubmed_authors><pubmed_authors>Herradon G</pubmed_authors><pubmed_authors>Lopez-Aceituno JL</pubmed_authors><pubmed_authors>McIntyre RL</pubmed_authors><pubmed_authors>Gomez J</pubmed_authors><pubmed_authors>Tapia-Gonzalez A</pubmed_authors><pubmed_authors>Sierra-Ramirez A</pubmed_authors><pubmed_authors>Fernandez-Marcos PJ</pubmed_authors><pubmed_authors>Fabregat-Safont D</pubmed_authors><pubmed_authors>Madeo F</pubmed_authors><pubmed_authors>Ballesteros-Gonzalez A</pubmed_authors><pubmed_authors>Galindo MI</pubmed_authors><pubmed_authors>Megias D</pubmed_authors><pubmed_authors>Houtkooper RH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models.</name><description>Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mit</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-05-29T13:00:53.485Z</modification><creation>2025-02-19T04:44:15.232Z</creation></dates><accession>S-EPMC10185515</accession><cross_references><pubmed>37188705</pubmed><doi>10.1038/s41467-023-38410-y</doi></cross_references></HashMap>